Patents by Inventor Byung-Joon Hwang

Byung-Joon Hwang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • genes encoding metabolic pathway proteins
    Patent number: 7510854
    Abstract: Isolated nucleic acid molecules, designated MP nucleic acid molecules, which encode novel MP proteins from Corynebacterium glutamicum are described. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing MP nucleic acid molecules, and host cells into which the expression vectors have been introduced. The invention still further provides isolated MP proteins, mutated MP proteins, fusion proteins, antigenic peptides and methods for the improvement of production of a desired compound from C. glutamicum based on genetic engineering of MP genes in this organism.
    Type: Grant
    Filed: September 28, 2005
    Date of Patent: March 31, 2009
    Assignee: Evonik Degussa GmbH
    Inventors: Markus Pompejus, Burkhard Kröger, Hartwig Schröder, Oskar Zelder, Gregor Haberhauer, Jun-Won Kim, Heung Shick-Lee, Byung-Joon Hwang
  • Methods and compositions relating to 5'-chimeric ribonucleic acids
    Publication number: 20040220127
    Abstract: The disclosure provides, among other things, methods for producing and using 5′-chimeric RNAs and cDNAs. 5′-chimeric RNAs and cDNAs may be used, for example, for high-throughput analysis of the 5′-end sequences for RNA transcripts.
    Type: Application
    Filed: August 11, 2003
    Publication date: November 4, 2004
    Inventors: Paul Sternberg, Byung Joon Hwang
  • Corynebacterium glutamicum genes encoding metabolic pathway proteins
    Publication number: 20030049804
    Abstract: Isolated nucleic acid molecules, designated MP nucleic acid molecules, which encode novel MP proteins from Corynebacterium glutamicum are described. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing MP nucleic acid molecules, and host cells into which the expression vectors have been introduced. The invention still further provides isolated MP proteins, mutated MP proteins, fusion proteins, antigenic peptides and methods for the improvement of production of a desired compound from C. glutamicurn based on genetic engineering of MP genes in this organism.
    Type: Application
    Filed: December 22, 2000
    Publication date: March 13, 2003
    Inventors: Markus Pompejus, Burkhard Kroger, Hartwig Schroder, Oskar Zelder, Gregor Haberhauer, Jun-Won Kim, Heung-Shick Lee, Byung-Joon Hwang